Literature DB >> 18178551

NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling.

Karine Enesa1, Mustafa Zakkar, Hera Chaudhury, Le A Luong, Lesley Rawlinson, Justin C Mason, Dorian O Haskard, Jonathan L E Dean, Paul C Evans.   

Abstract

Transcription factors belonging to the NF-kappaB family regulate inflammation by inducing pro-inflammatory molecules (e.g. interleukin (IL)-8) in response to cytokines (e.g. tumor necrosis factor (TNF) alpha, IL-1) or other stimuli. Several negative regulators of NF-kappaB, including the ubiquitin-editing enzyme A20, participate in the resolution of inflammatory responses. We report that Cezanne, a member of the A20 family of the deubiquitinating cysteine proteases, can be induced by TNFalpha in cultured cells. Silencing of endogenous Cezanne using small interfering RNA led to elevated NF-kappaB luciferase reporter gene activity and enhanced expression of IL-8 transcripts in TNFalpha-treated cells. Thus we conclude that endogenous Cezanne can attenuate NF-kappaB activation and the induction of pro-inflammatory transcripts in response to TNF receptor (TNFR) signaling. Overexpression studies revealed that Cezanne suppressed NF-kappaB nuclear translocation and transcriptional activity by targeting the TNFR signaling pathway at the level of the IkappaB kinase complex or upstream from it. These effects were not observed in a form of Cezanne that was mutated at the catalytic cysteine residue (Cys209), indicating that the deubiquitinating activity of Cezanne is essential for NF-kappaB regulation. Finally, we demonstrate that Cezanne can be recruited to activated TNFRs where it suppresses the build-up of polyubiquitinated RIP1 signal adapter proteins. Thus we conclude that Cezanne forms a novel negative feedback loop in pro-inflammatory signaling and that it suppresses NF-kappaB activation by targeting RIP1 signaling intermediaries for deubiquitination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178551     DOI: 10.1074/jbc.M708690200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

1.  Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling.

Authors:  Puck B van Kasteren; Corrine Beugeling; Dennis K Ninaber; Natalia Frias-Staheli; Sander van Boheemen; Adolfo García-Sastre; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Ubiquitination: Added complexity in Ras and Rho family GTPase function.

Authors:  Michelle de la Vega; James F Burrows; James A Johnston
Journal:  Small GTPases       Date:  2011-07-01

Review 3.  Signaling to NF-kappaB: regulation by ubiquitination.

Authors:  Ingrid E Wertz; Vishva M Dixit
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

Review 4.  Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections.

Authors:  Wenzhuo Y Wang; Jae Hyang Lim; Jian-Dong Li
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

5.  DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB.

Authors:  R Sean McNally; Beckley K Davis; Casey M Clements; Mary Ann Accavitti-Loper; Tak W Mak; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

6.  De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-kappaB/IKK basal activity.

Authors:  Linda Palma; Rita Crinelli; Marzia Bianchi; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2009-05-07       Impact factor: 3.396

7.  Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.

Authors:  Ping Li; Ying Wang; Justin H Turner
Journal:  Int Forum Allergy Rhinol       Date:  2015-04-24       Impact factor: 3.858

Review 8.  Breaking the chains: structure and function of the deubiquitinases.

Authors:  David Komander; Michael J Clague; Sylvie Urbé
Journal:  Nat Rev Mol Cell Biol       Date:  2009-08       Impact factor: 94.444

9.  USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.

Authors:  Pierre-Yves Jean-Charles; Jiao-Hui Wu; Lisheng Zhang; Suneet Kaur; Igor Nepliouev; Jonathan A Stiber; Leigh Brian; Rui Qi; Virginia Wertman; Sudha K Shenoy; Neil J Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

10.  miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops.

Authors:  Libing Song; Chuyong Lin; Hui Gong; Chanjuan Wang; Liping Liu; Jueheng Wu; Sha Tao; Bo Hu; Shi-Yuan Cheng; Mengfeng Li; Jun Li
Journal:  Cell Res       Date:  2012-12-18       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.